Filter Results :

Your search for Pharmaceuticals returned 5179 reports

Sort by


Australia Pharmaceuticals and Healthcare Report

27 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: As the Australian government continues to focus on cost containment while at the same time increasing the population's access to innovative medicines, companies will increasingly need to justify the price of their treatments by demonstrating their value to the broader healthcare syst...

$ 1,295.00

Read More

United Kingdom Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Although we retain our view that the UK will remain a member of the European Union after the Brexit referendum to be held on June 23, uncertainty over the outcome increased in the first months of 2016, and a Brexit would pose significant challenges to the UK and European pharmaceutic...

$ 1,295.00

Read More

Iran Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: With sanctions lifted, Iran has improving prospects of opening up to a wider diversity of trading partners and providing strategic opportunities for multinational pharmaceutical companies. By reintegrating into the financial transaction system SWIFT, the import of pharmaceutical-rela...

$ 1,295.00

Read More

Israel Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Our growth outlook for Israel's pharmaceutical sector is underpinned by the government package to systematically bolster the public health system through targeted investment in health resources and infrastructure. Concerted efforts to grow the interface between private and public m...

$ 1,295.00

Read More

Algeria Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Algerian pharmaceutical market will remain attractive to multinational drugmakers, despite the slow pace of improvements in the regulatory and market access environment. Key market drivers such as growing demand for healthcare, rising chronic disease burden and sustained foreign ...

$ 1,295.00

Read More

Angola Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Like other oil-dependent countries, Angola has suffered from the large fall in the price of oil. The healthcare sector has been impacted by large budget cuts as a result of the lower government revenues. With waste collection services also affected by severe cuts, the country is expe...

$ 1,295.00

Read More

Zambia Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Real GDP growth in Zambia will remain subdued in 2016 at 3.4% due to a struggling copper industry and persistent power shortages. Private consumption will be restrained by higher interest rates and food costs stemming from a weak currency. Government expenditure maintains a focus on ...

$ 1,295.00

Read More

Qatar Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Qatar's pharmaceuticals and healthcare sectors will continue to grow despite challenges facing the government's revenue streams. Both an increase in public spending on health, including in infrastructure projects, and the rising participation of the private sector in healthcare fundi...

$ 1,295.00

Read More

El Salvador Pharmaceuticals and Healthcare Report

20 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: El Salvador's pharmaceutical market will remain unattractive in the years ahead. While the government's commitment to healthcare in El Salvador will continue to improve the national healthcare system and increase patients' access to medicines, the country's small market size, low per...

$ 1,295.00

Read More

Nicaragua Pharmaceuticals and Healthcare Report

13 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Access to affordable medicine will continue to be challenging for the majority of Nicaraguans in the coming years. Limited healthcare funding, low per capita pharmaceutical expenditure, a small and unregulated drug market and the socio-cultural preference for traditional medicines wi...

$ 1,295.00

Read More

Panama Pharmaceuticals and Healthcare Report

13 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Panama's decision to move forward with the unification of its public healthcare system will have a significant positive impact on the improvement of medical services in the country over the long term. The planned operational enhancements will also increase medicine consumption and de...

$ 1,295.00

Read More

Guatemala Pharmaceuticals and Healthcare Report

13 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The commercial incentives for foreign drugmakers to further expand in Guatemala's pharmaceutical market are limited by the country's low per capita pharmaceutical spending and subdued market growth. However, in spite of this, the country will continue to attract investment as a regio...

$ 1,295.00

Read More

Peru Pharmaceuticals and Healthcare Report

13 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: In spite of its small market size and developing health care system, its promising economic outlook and its government's commitment to increased investment in the healthcare sector will be factors contributing to the improvement of Peru's pharmaceutical business environment. We belie...

$ 1,295.00

Read More

Puerto Rico Pharmaceuticals and Healthcare Report

13 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Despite short-term headwinds due to fiscal tightening, Puerto Rico's pharmaceutical market is expected to observe modest positive growth over the next five years. This slightly improved outlook already represents a recovery trend against the negative market growth patterns observed i...

$ 1,295.00

Read More

United Arab Emirates Pharmaceuticals and Healthcare Report

13 Apr 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The sixth initiative of the UAE's medicine price reduction process will not significantly affect the country's pharmaceutical market. For drugmakers in the region, lower profit margins will be offset by increasing sales volumes. The UAE will continue to rely on imported medicines; ho...

$ 1,295.00

Read More
Total 5179 records.